Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
Ophthalmology
|
November 29, 2016
Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients
Ravi Parikh, Joseph S Ross, Lindsey R Sangaralingham, et al.
JAMA Ophthalmology
|
October 31, 2024
Use of Artificial Intelligence-Based Detection of Diabetic Retinopathy in the US
Shreya A Shah, Jared T Sokol, Karen M Wai, et al.
Journal of Comparative Effectiveness Research
|
October 28, 2025
Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2
Amanda M Kong, Dionna Andrean, Saarah Khan, et al.
Taiwan Journal of Ophthalmology
|
January 13, 2021
Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year
Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, et al.
Journal of Clinical Medicine
|
August 6, 2020
Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
Yoshiko Fukuda, Yoichi Sakurada, Atsushi Sugiyama, et al.
Ophthalmology. Retina
|
July 22, 2020
Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy
Amee D Azad, Evan M Chen, John Hinkle, et al.
Ophthalmology. Retina
|
October 11, 2020
Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy
Amee D Azad, Evan M Chen, John Hinkle, et al.
Digital Journal of Ophthalmology : DJO
|
April 27, 2023
Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021
Sachi A Patil, Daniel G Vail, Jacob T Cox, et al.
Ophthalmology
|
June 29, 2026
Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service
Jennifer Chan, Michael X Repka, George A Williams, et al.
JAMA Ophthalmology
|
January 11, 2019
Comparison of Ophthalmic Medication Prices Between the United States and Australia
Ravi Parikh, Paula W Feng, Laurel Tainsh, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
Ophthalmology
|
November 29, 2016
Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients
Ravi Parikh, Joseph S Ross, Lindsey R Sangaralingham, et al.
JAMA Ophthalmology
|
October 31, 2024
Use of Artificial Intelligence-Based Detection of Diabetic Retinopathy in the US
Shreya A Shah, Jared T Sokol, Karen M Wai, et al.
Journal of Comparative Effectiveness Research
|
October 28, 2025
Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2
Amanda M Kong, Dionna Andrean, Saarah Khan, et al.
Taiwan Journal of Ophthalmology
|
January 13, 2021
Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year
Sumit Randhir Singh, Ravi Parikh, Yoichi Sakurada, et al.
Journal of Clinical Medicine
|
August 6, 2020
Title: Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
Yoshiko Fukuda, Yoichi Sakurada, Atsushi Sugiyama, et al.
Ophthalmology. Retina
|
July 22, 2020
Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy
Amee D Azad, Evan M Chen, John Hinkle, et al.
Ophthalmology. Retina
|
October 11, 2020
Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy
Amee D Azad, Evan M Chen, John Hinkle, et al.
Digital Journal of Ophthalmology : DJO
|
April 27, 2023
Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021
Sachi A Patil, Daniel G Vail, Jacob T Cox, et al.
Ophthalmology
|
June 29, 2026
Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service
Jennifer Chan, Michael X Repka, George A Williams, et al.
JAMA Ophthalmology
|
January 11, 2019
Comparison of Ophthalmic Medication Prices Between the United States and Australia
Ravi Parikh, Paula W Feng, Laurel Tainsh, et al.
Page
of 11